iBio (IBIO) Other financing activities (2014 - 2026)
iBio (IBIO) posted quarterly Other financing activities of $1.7 million for Q1 2026, up 1612.92% year-over-year from $99246.0 in Q1 2025, and down 43.33% quarter-over-quarter from $3.0 million in Q4 2025.
iBio (IBIO) Other financing activities (2014 - 2026) Analysis & Trends
iBio (IBIO) has reported Other financing activities for 11 consecutive years, with $1.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other financing activities rose 1612.92% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $4.6 million (down 79.8% YoY), while the FY2025 annual figure was $113.0, down 100.0% from the prior year.
- Other financing activities eased to $1.7 million in Q1 2026 per IBIO's latest filing, from $3.0 million in the prior quarter.
- Across five years, Other financing activities topped out at $18.1 million in Q4 2024 and bottomed at -$129887.0 in Q2 2025.
- Historically, Other financing activities has averaged $3.3 million across 4 years, with a median of $1.7 million in 2026.
- Annual changes were most pronounced in 2025 — Other financing activities slumped 102.91% — and 2026, when it soared 1612.92%.
- iBio's Other financing activities stood at $2.2 million in 2023, then jumped by 726.54% to $18.1 million in 2024, then plunged by 83.39% to $3.0 million in 2025, then plunged by 43.33% to $1.7 million in 2026.
- Business Quant data shows IBIO's Other financing activities at $1.7 million in Q1 2026, $3.0 million in Q4 2025, and $30.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.70 Mn |
| Mar 31, 2026 | 1.70 Mn |
| Dec 31, 2025 | 3.00 Mn |
| Dec 31, 2025 | 3.00 Mn |
| Sep 30, 2025 | 30.00 |
| Sep 30, 2025 | 30.00 |
| Jun 30, 2025 | -129,887.00 |
| Jun 30, 2025 | -129,887.00 |
| Mar 31, 2025 | 99,246.00 |
| Mar 31, 2025 | 99,246.00 |
| Dec 31, 2024 | 18.06 Mn |
| Dec 31, 2024 | 18.06 Mn |
| Jun 30, 2024 | 4.46 Mn |
| Jun 30, 2024 | 4.46 Mn |
| Mar 31, 2024 | -7,000.00 |
| Mar 31, 2024 | -7,000.00 |
| Jun 30, 2023 | 2.19 Mn |
| Jun 30, 2023 | 2.19 Mn |
| Dec 31, 2021 | 77,000.00 |
| Dec 31, 2021 | 77,000.00 |